These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1451725)
1. Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man. Depré M; Margolskee DJ; Hsieh JY; Van Hecken A; Buntinx A; De Lepeleire I; Rogers JD; De Schepper PJ Eur J Clin Pharmacol; 1992; 43(4):427-30. PubMed ID: 1451725 [TBL] [Abstract][Full Text] [Related]
2. Dose-dependent kinetics of the enantiomers of MK-571, and LTD4-receptor antagonist. Depré M; Margolskee DJ; Van Hecken A; Hsieh JS; Buntinx A; De Schepper PJ; Rogers JD Eur J Clin Pharmacol; 1992; 43(4):431-3. PubMed ID: 1451726 [TBL] [Abstract][Full Text] [Related]
3. Stereoselective determination of R(-)- and S(+)-MK-571, a leukotriene D4 antagonist, in human plasma by chiral high-performance liquid chromatography. Robinett RS; Hsieh JY J Chromatogr; 1991 Sep; 570(1):157-65. PubMed ID: 1797821 [TBL] [Abstract][Full Text] [Related]
4. Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679. Impens N; Reiss TF; Teahan JA; Desmet M; Rossing TH; Shingo S; Zhang J; Schandevyl W; Verbesselt R; Dupont AG Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1442-6. PubMed ID: 8389106 [TBL] [Abstract][Full Text] [Related]
5. Physiological disposition of aerosolized MK-679 in rats. Tocco DJ; deluna FA; Vadas E; Lin JH Drug Metab Dispos; 1992; 20(3):428-31. PubMed ID: 1355719 [TBL] [Abstract][Full Text] [Related]
6. Oral pharmacokinetics and food interaction of the leukotriene D4 receptor antagonist verlukast. Schwartz JI; Margolskee DJ; Bjornsson TD; Williams VC; Hsieh JY; Lin CC; Rogers JD Br J Clin Pharmacol; 1993 Nov; 36(5):464-6. PubMed ID: 12959296 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Cheng H; Leff JA; Amin R; Gertz BJ; De Smet M; Noonan N; Rogers JD; Malbecq W; Meisner D; Somers G Pharm Res; 1996 Mar; 13(3):445-8. PubMed ID: 8692739 [TBL] [Abstract][Full Text] [Related]
8. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125 [TBL] [Abstract][Full Text] [Related]
9. Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist. Lin JH; deLuna FA; Ulm EH; Tocco DJ Drug Metab Dispos; 1990; 18(4):484-7. PubMed ID: 1976072 [TBL] [Abstract][Full Text] [Related]
10. Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers. Schoors DF; De Smet M; Reiss T; Margolskee D; Cheng H; Larson P; Amin R; Somers G Br J Clin Pharmacol; 1995 Sep; 40(3):277-80. PubMed ID: 8527292 [TBL] [Abstract][Full Text] [Related]
11. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma. Rasmussen JB; Eriksson LO; Margolskee DJ; Tagari P; Williams VC; Andersson KE J Allergy Clin Immunol; 1992 Aug; 90(2):193-201. PubMed ID: 1323587 [TBL] [Abstract][Full Text] [Related]
12. The bioavailability and nonlinear pharmacokinetics of MK-679 in humans. Cheng H; Schwartz JI; Lin C; Amin RD; Seibold JR; Lasseter KC; Ebel DL; Tocco DJ; Rogers JD Biopharm Drug Dispos; 1994 Jul; 15(5):409-18. PubMed ID: 7981429 [TBL] [Abstract][Full Text] [Related]
13. Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571. Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Gauthier JY; Leger S; Lord A; Masson P Can J Physiol Pharmacol; 1991 Dec; 69(12):1847-54. PubMed ID: 1666333 [TBL] [Abstract][Full Text] [Related]
14. Stereospecific HPLC method for the quantitation of the enantiomers of MK-0571, a potent leukotriene D4 receptor antagonist, in biological specimens. Lee LL; Zacchei AG Chirality; 1991; 3(2):129-35. PubMed ID: 1650571 [TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic method for the determination of a novel leukotriene D4 antagonist (MK-0571) in biological specimens. Berna RA; Zacchei AG J Chromatogr; 1991 Feb; 563(2):458-65. PubMed ID: 2056010 [TBL] [Abstract][Full Text] [Related]
16. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human. Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase-activating protein inhibitor. Depré M; Friedman B; Van Hecken A; de Lepeleire I; Tanaka W; Dallob A; Shingo S; Porras A; Lin C; de Schepper PJ Clin Pharmacol Ther; 1994 Jul; 56(1):22-30. PubMed ID: 8033491 [TBL] [Abstract][Full Text] [Related]
18. Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571. Rasmussen JB; Margolskee DJ; Eriksson LO; Williams VC; Andersson KE Ann N Y Acad Sci; 1991; 629():436. PubMed ID: 1952571 [No Abstract] [Full Text] [Related]
19. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma. Wahedna I; Wisniewski AS; Tattersfield AE Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449 [TBL] [Abstract][Full Text] [Related]
20. Effects of timolol, indomethacin, and MK-571 on bronchoconstriction to infused leukotriene D4 in guinea pigs. Masson P; Jones TR Can J Physiol Pharmacol; 1990 Jul; 68(7):783-90. PubMed ID: 2383794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]